Excerpt from Angiokeratoma CircumscriptumSynonyms, Key Words, and Related Terms: AC, angiokeratomata circumscripta, angiokeratoma corporis neviform, capillary malformation Please click here to view the full topic text: Angiokeratoma CircumscriptumBackgroundAngiokeratomas are a group of vascular ectasias that involve the papillary dermis and may produce papillomatosis, acanthosis, and hyperkeratosis of the epidermis. Several clinical variants of angiokeratomas exist; angiokeratoma circumscriptum (AC) is one type, and the least frequent of the other types of angiokeratomas. Overall, 8 types of angiokeratomas have been described in the literature. The first reported case dates as far back as 1889 when Mibelli described what is now known as angiokeratoma Mibelli-type on the fingers and the toes. Fabry first described AC in 1915 as a localized lesion on a lower extremity or the trunk. In addition, a rare manifestation of AC naviforme, with appearance on the neck, has been documented. These lesions are of clinical importance because they may clinically mimic a malignant melanoma. In many cases, the lesions are present at birth, but they may appear in childhood or adulthood. AC has been reported to coexist with angiokeratoma of Fordyce (found on the scrotum) and caviar spots (angiokeratomas of the tongue). Other clinical associations include its occurrence with Cobb syndrome, Klippel-Trenaunay syndrome, nevus flammeus, cavernous hemangiomas, hemangiectatic hypertrophy, angiokeratoma corporis diffusum, and traumatic arteriovenous fistulas. AC has also been called angiokeratoma corporis neviform and may be best classified as a type of capillary malformation. PathophysiologyAs Imperial and Helwig discussed in 1967, angiokeratomas are not true angiomas but rather telangiectasias of preexisting vessels. The mechanism for development of AC is unknown. Several causal factors, such as congenital development, pregnancy, trauma, subcutaneous hematomas, and tissue asphyxia, have all been proposed. Interestingly, lymphangioma circumscriptum, an entity that is microscopically similar to AC, has been reported to occur in a setting of damaged deep lymphatic vessels. Unlike angiokeratoma of Mibelli or angiokeratoma corporis diffusum (Fabry disease), no pattern of inheritance or associated enzyme defect has been found for AC. Overall, altered hemodynamics (typically caused by trauma) appear to produce telangiectatic vessels of the papillary dermis with an overlying reactive hyperkeratosis to the epidermis. FrequencyUnited StatesThe frequency of AC is unknown. However, it is probably more common than what the relatively few cases in the literature indicate. Because no associated systemic morbidity occurs, most cases remain clinically innocuous and go unreported. Mortality/MorbidityAC is a benign vessel ectasia involving the papillary dermis. No deaths from this entity have been reported. However, because it may clinically mimic a melanoma, morbidity may arise from attempts to render treatment for a melanoma before histologic verification is given. Furthermore, because angiokeratomata are vascular lesions, recurrent bleeding can occur. Life-threatening bleeding is not a concern, probably because of the small size of the affected vascular spaces. RaceNo ethnic predilection has been observed or reported to date. SexWomen are affected more commonly than men, in a ratio of approximately 3:1. AgeAC may be either congenital or acquired. Lesions are not uncommonly present at birth, but development in early childhood and even adulthood has been documented. Please click here to view the full topic text: Angiokeratoma Circumscriptum |
| About Us | Privacy | Code of Ethics | Terms of Use | Contact Us | Advertising | Institutional Subscribers |
|
|
|||
|
| Medicine is a constantly changing science and not all therapies are clearly established. New research changes drug and treatment therapies daily. The authors, editors, and publisher of this journal have used their best efforts to provide information that is up-to-date and accurate and is generally accepted within medical standards at the time of publication. However, as medical science is constantly changing and human error is always possible, the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. FULL DISCLAIMER |